India Oncology NGS Market (2025-2031) | Segmentation, Value, Size & Revenue, Trends, Analysis, Share, Outlook, Companies, Competitive Landscape, Growth, Forecast, Industry

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Oncology NGS Market Revenues & Volume, 2021 & 2031F

3.3 India Oncology NGS Market - Industry Life Cycle

3.4 India Oncology NGS Market - Porter's Five Forces

3.5 India Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.6 India Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 India Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F

3.8 India Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F

3.9 India Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing adoption of precision medicine in oncology

4.2.3 Technological advancements in next-generation sequencing (NGS) for oncology research

4.3 Market Restraints

4.3.1 High cost associated with NGS technologies

4.3.2 Regulatory challenges in the healthcare sector

4.3.3 Lack of skilled professionals in the field of oncology NGS

6.1 India Oncology NGS Market, By Technology

6.1.1 Overview and Analysis

6.1.2 India Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F

6.1.3 India Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.1.4 India Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2 India Oncology NGS Market, By Application

6.2.1 Overview and Analysis

6.2.2 India Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F

6.2.3 India Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F

6.3 India Oncology NGS Market, By Service

6.3.1 Overview and Analysis

6.3.2 India Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F

6.3.3 India Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F

6.4 India Oncology NGS Market, By Workflow

6.4.1 Overview and Analysis

6.4.2 India Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F

6.4.3 India Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F

6.4.4 India Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F

6.5 India Oncology NGS Market, By End-use

6.5.1 Overview and Analysis

6.5.2 India Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F

6.5.3 India Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F

6.5.4 India Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.5.5 India Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F

6.5.6 India Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F

7.1 India Oncology NGS Market Export to Major Countries

7.2 India Oncology NGS Market Imports from Major Countries

8.1 Number of research collaborations between healthcare institutions and technology companies for oncology NGS

8.2 Rate of adoption of NGS technologies in oncology treatments

8.3 Number of clinical trials utilizing NGS for personalized cancer therapy

9.1 India Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F

9.2 India Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 India Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F

9.4 India Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F

9.5 India Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F

10.1 India Oncology NGS Market Revenue Share, By Companies, 2024

10.2 India Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters